Clerkenwell Health
Europe's only neuro & psychiatry specialist CRO & trial site network, accelerating trial delivery since 2021
Europe's only neuro & psychiatry specialist CRO & trial site network, accelerating trial delivery since 2021
Clerkenwell Health is a UK-based startup founded in 2020. The company's slogan, "Europe's only neuro & psychiatry specialist CRO & trial site network, accelerating trial delivery since 2021," reflects its focus on clinical research and care delivery for mental health and neurological treatments. Specializing in the Health Care and Pharmaceutical industries, Clerkenwell Health offers CRO services, a site network, and therapist training programs to support life sciences companies in developing and launching new treatments.
The company's recent milestone includes a £2.10M Seed Round investment on 10 October 2022, with participation from Convergence Partners, Lionheart Ventures, Exceptional Ventures, Matt Cooper, and Christer Holloman. Clerkenwell Health aims to bridge the gap between research and treatment by providing access to new therapies through clinical trials and an international network of clinics. Overall, the company is positioned to play a vital role in advancing mental health and neurological treatments while addressing the critical need for specialized care delivery in these areas.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | £2.10M | 5 |
|
10 Oct 2022 |
| Pre Seed Round | Unknown | 1 |
|
01 Feb 2022 |
| Seed Round | Unknown | 1 | Christer Holloman | 25 Jun 2021 |
| Pre Seed Round | Unknown | 1 |
|
01 Feb 2021 |
No recent news or press coverage available for Clerkenwell Health.
We care about your data, and we'd love to use cookies make your experience better.
